[IMG] Ed Rychlick Vice President of Aquapheresis Ed Rychlick...

Ed Rychlick
Vice President of Aquapheresis
Ed Rychlick joined Sunshine Heart in May 2016 as the Vice President and General Manager.

With over 25 years of experience and co-creator/co-inventor of the award winning Aquadex Flexflow device, Mr. Rychlick has worked in multiple roles of increasing responsibility throughout the complete medical device lifecycle from concept, to commercialization, to globalization. With a special focus on heart failure and cardiorenal syndrome, Mr. Rychlick has most recently worked with Baxter International as Director of Global Marketing, Gambro AB as Director of Therapy Development, and with CHF Solutions in numerous roles.

From engineering, clinical research, operations, market research, new product planning and launch, sales, and marketing, Mr. Rychlick provides unique, cross functional and diverse skills and experiences with a focus on complete therapy and multi-product portfolio strategy, management, marketing, and commercialization.

Mr. Rychlick currently holds 15 patents and received a Bachelor of Science degree from Harvard University in electrical, computer, and systems engineering and a Master’s of Science degree from the University of Michigan in Electrical/Biomedical Engineering and BioSystems.


Joined in may 3 months before the deal was announced

All the current strategy movements have been pre planned

We will partner very soon imo

Lets hope no splits are involved

If we can go from 0.4 to 1.6 in 3 weeks on no news

We can go to $3+ with good news

Hoping for the best been a long fkn wait